Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Journal of ECT
|
September 27, 2000
ECT in a patient with a deep brain-stimulating electrode in place
F M Moscarillo, C M Annunziata
Cell Death & Disease
|
January 19, 2016
Caspase 8 expression may determine the survival of women with ovarian cancer
M Kim, L Hernandez, C M Annunziata
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 11, 2008
Ovarian cancer in the proteomics era
C M Annunziata, N Azad, A S Dhamoon, et al.
Blood
|
October 7, 2000
Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor
C M Annunziata, Y J Safiran, S G Irving, et al.
British Journal of Cancer
|
January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
J-M Lee, G A Sarosy, C M Annunziata, et al.
British Journal of Cancer
|
July 23, 2013
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
D H Moon, J-M Lee, A M Noonan, et al.
Blood
|
July 9, 1999
Reed-Sternberg cell genome expression supports a B-cell lineage
J Cossman, C M Annunziata, S Barash, et al.
Cell Death Discovery
|
February 10, 2017
A dual role for Caspase8 and NF-<i>κ</i>B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival
L Hernandez, M K Kim, A M Noonan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Journal of ECT
|
September 27, 2000
ECT in a patient with a deep brain-stimulating electrode in place
F M Moscarillo, C M Annunziata
Cell Death & Disease
|
January 19, 2016
Caspase 8 expression may determine the survival of women with ovarian cancer
M Kim, L Hernandez, C M Annunziata
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 11, 2008
Ovarian cancer in the proteomics era
C M Annunziata, N Azad, A S Dhamoon, et al.
Blood
|
October 7, 2000
Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor
C M Annunziata, Y J Safiran, S G Irving, et al.
British Journal of Cancer
|
January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
J-M Lee, G A Sarosy, C M Annunziata, et al.
British Journal of Cancer
|
July 23, 2013
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
D H Moon, J-M Lee, A M Noonan, et al.
Blood
|
July 9, 1999
Reed-Sternberg cell genome expression supports a B-cell lineage
J Cossman, C M Annunziata, S Barash, et al.
Cell Death Discovery
|
February 10, 2017
A dual role for Caspase8 and NF-<i>κ</i>B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival
L Hernandez, M K Kim, A M Noonan, et al.
Page
of 1